Skip to main content
. 2017 Jul 3;31(4):677–682. doi: 10.21873/invivo.11112

Figure 3. Retrospective complication rates for SurgiMend®, Epiflex® and Tutomesh®. SurgiMend® data have been pooled with (10) in order to increase the number of samples (n). Epiflex® data was also first presented in (10). Tutomesh® data was collected in this trial only.

Figure 3